期刊文献+

啮齿类糖尿病肾病动物模型研究进展 被引量:4

下载PDF
导出
出处 《中国中医基础医学杂志》 CAS CSCD 北大核心 2006年第7期530-532,543,共4页 JOURNAL OF BASIC CHINESE MEDICINE
  • 相关文献

参考文献13

  • 1Janssen U,Phillips AO,Floege J.Rodent models of nephropathy associated with type Ⅱ diabetes[J].J Nephrol,1999,12(3):159-172.
  • 2Allen TJ,Cooper ME,Lan HY.Use of Genetic Mouse Models in the Study of Diabetic Nephropathy[J].Curr Diab Rep,2004,4(6):435-440.
  • 3Osterby R,Gundersen HJ.Glomerular size and structure in diabetes mellitus.Ⅰ.Early abnormalities[J].Diabetologia,1975,11(3):225-229.
  • 4Gundersen HJ,Osterby R.Glomerular size and structure in diabetes mellitus.Ⅱ.Late abnormalities[J].Diabetologia,1977,13(1):43-48.
  • 5Janssen U,Vassiliadou A,Riley SG,et al.The quest for a model of type Ⅱ diabetes with nephropathy:the Goto Kakizaki rat[J].J Nephro,2004,17(6):769-773.
  • 6Sato N,Komatsu K,Kurumatani H.Late Onset of Diabetic Nephropathy in Spontaneously Diabetic GK Rats[J].A J Nephrol,2003,23(5):334-342.
  • 7Popov D,Simionescu M,Shepherd PR.Saturated-fat diet induces moderate diabetes and severe glomerulosclerosis in ham sters[J].Diabetologia,2003,46(10):1408-1418.
  • 8郭啸华,刘志红,李恒,黎磊石.高糖高脂饮食诱导的2型糖尿病大鼠模型及其肾病特点[J].中国糖尿病杂志,2002,10(5):290-294. 被引量:304
  • 9Hammad SM,Hazen-Martin DJ,Sohn M,et al.Nephropathy in a hypercholesterolemic mouse model with streptozotociv-induced diabetes[J].Kidney Blood Press Res,2003,26(5-6):351-361.
  • 10Yokozawa T,Nakagawa T,Wakaki K,Koizumi F.Animal model of diabetic nephropathy[J].Exp Toxicol Pathol,2001,53 (5):359-363.

二级参考文献10

  • 1Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocrine Reviews, 1985,6 : 45-86.
  • 2Bryer-Ash M, Foilett L, Hodges N, et al. Amylin-mediated reduction in insulin sensitivity corresponds to reduced insulin receptor activity in the rat in vivo. Metabolism, 1995,44:705-711.
  • 3Proietto J, Filippis A, Nakhla C, et al. Nutrient-induced insulin resistance. Mol Cell Endocrinol, 1999,151:143-149.
  • 4Fioretto P, Mauer M, Brocco E, et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia,1996,39:1569-1576.
  • 5Joles JA, Kunter U, Janssen U, et al. Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats.J Am Soc Nephrol, 2000,11 : 669-683.
  • 6Dominguez JH, Tang N, Xu W, et al. Studies of renal injury Ⅲ: lipid-induced nephropathy in type Ⅱ diabetes. Kidney Int,2000,57 : 92-104.
  • 7Ravid M, Brosh D, Ravid-Safran D, et al. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Inter Mecl, 1998,158:998-1004.
  • 8Daniels MC, McClain DA, Crook ED. Transcriptional regulation of transforming growth factor beta by glucose: investigation into the role of the hexosamine biosynthesis pathway. Am J Med Sci, 2000,319:138-142.
  • 9Michel O, Heudes D, Lamarre I, et al. Reduction of insulin and triglycerides delays glomerulosclerosis in obese Zucker rats. Kidney Int, 1997,52:1532-1542.
  • 10李颖健,刘志红,刘栋,朱加明,郭啸华,黎磊石.己糖胺通路的活化介导系膜细胞转化生长因子β1的表达[J].肾脏病与透析肾移植杂志,2000,9(4):303-310. 被引量:12

共引文献303

同被引文献36

  • 1娄季宇,曾志磊,杨霄鹏.不同剂量促红细胞生成素对大鼠脑缺血再灌注损伤后神经细胞凋亡的影响[J].郑州大学学报(医学版),2006,41(2):316-318. 被引量:27
  • 2Mojiminiyi OA, Abdella NA, Zaki MY, et al. Prevalence and associations of low plasma erythropoietin in patients with Type 2 diabetes mellitus [J]. Diabet Med, 2006, 23(8):839-844.
  • 3McGill JB, Bell DSH. Anemia and the role of erythropoietin in diabetes [J]. J Diabetes Complications, 2006, 20(4):262-272.
  • 4Yalcin S, Muftuoglu S, Cetin E, et al. Protection against cisplatin-induced nephrotoxicity by recombinant human erythropoietin [J]. Med Oncol, 2003, 20(2):169-174.
  • 5Lee SH, Li C, Lim SW, et al. Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy [J]. Am J Nephrol, 2005, 25 (1) :64-76.
  • 6Kumral A, Uysal N, Tugyan K, et al. Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats [J]. Behav Brain Res, 2004, 153(1) :77-86.
  • 7Moon C, Krawczyk M, Paik D, et al. Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window [J]. Cardiovasc Drugs Ther, 2005, 19(4):243-250.
  • 8Sekiguchi N, lnoguchi T, Kobayashi K, et al. Effect of erythropoietin on endothelial cell apoptosis induced by high glucose [J]. Diabetes Res Clin Praet, 2004, 66(suppl 1):103-107.
  • 9Maiese K, Li F, Chong ZZ. Erythropoietin in the brain, can the promise to protect be fulfilled [J]. Trends Pharmacol Sci, 2004, 25(11):577-583.
  • 10Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors [J]. Kidney Int, 1999, 55(3) :808-820.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部